Since the tracer kinetics of Flortaucipir differs between off-target binding regions, such as the putamen, and binding to AD tau pathology in the cerebral cortex32 future kinetic studies may shed light on the nature of the cortical tracer retention in svPPA. This evidence concerns the gene MAPT and Alzheimer disease.